Nicholas H. Vetter

Nicholas Vetter is currently the CEO and Managing Director at OncoBeta, a company focused on epidermal radioisotope therapy for Non Melanoma Skin Cancer. In addition, Nicholas holds various roles in other companies such as RV Invest, UV Cap GmbH and Co KG, Protembis GmbH, Perfood GmbH, Vetter Pharma, and Patchai. With a background in Integrative Physiology and German Literature, Nicholas also holds an MBA from SDA Bocconi.